Skip to main content

Table 3 Table showing localisation of metastasis, pathologic and treatment characteristics and outcome of patients with metastatic disease at presentation.

From: Outcome of recurrent and metastatic small cell carcinoma of the bladder

Localisation of metastasis Histology (Mixed or pure SmCC) Treatment Response Survival (months) Death
Liver and Lung and Mediastinum Mixed CT (22EP) PR > 70% 51.8 no
Lung and bone Pure CT (4EP) + RT (Y 45 Gy) + RT in the bladder (24 Gy). PR < 50% 11.7 yes
Bone Pure none NA 1 yes
  1. SmCC = small cell carcinoma; CNS = central nervous system; RP = retroperitoneal; EP = etoposide and cisplatin; G = gemcitabine; GC = gemcitabine plus cisplatin; MVAC = methotrexate, vinblastine, doxorubicin and cisplatin; MTX = methotrexate; CT = chemotherapy; RT = radiotherapy; Y = Y field radiotherapy; PR = partial response; NA = not applicable